These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 31696388)

  • 1. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
    Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
    Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADC at 3.0 T as a noninvasive biomarker for preoperative prediction of Ki67 expression in invasive ductal carcinoma of breast.
    Shen L; Zhou G; Tong T; Tang F; Lin Y; Zhou J; Wang Y; Zong G; Zhang L
    Clin Imaging; 2018; 52():16-22. PubMed ID: 29501957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer.
    Liang C; Cheng Z; Huang Y; He L; Chen X; Ma Z; Huang X; Liang C; Liu Z
    Acad Radiol; 2018 Sep; 25(9):1111-1117. PubMed ID: 29428211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer Ki67 expression prediction by DCE-MRI radiomics features.
    Ma W; Ji Y; Qi L; Guo X; Jian X; Liu P
    Clin Radiol; 2018 Oct; 73(10):909.e1-909.e5. PubMed ID: 29970244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
    Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
    J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
    Zhuang Z; Zhang Q; Zhang D; Cheng F; Suo S; Geng X; Hua J; Xu J
    Clin Radiol; 2018 May; 73(5):473-478. PubMed ID: 29273228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
    Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
    Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the HER-2 status of breast cancer using mammography radiomics features.
    Zhou J; Tan H; Bai Y; Li J; Lu Q; Chen R; Zhang M; Feng Q; Wang M
    Eur J Radiol; 2019 Dec; 121():108718. PubMed ID: 31711023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.
    Feng S; Yin J
    Front Oncol; 2022; 12():847880. PubMed ID: 36895526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficient on 3.0 Tesla magnetic resonance imaging and prognostic factors in breast cancer.
    De Felice C; Cipolla V; Guerrieri D; Santucci D; Musella A; Porfiri LM; Meggiorini ML
    Eur J Gynaecol Oncol; 2014; 35(4):408-14. PubMed ID: 25118482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
    Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
    NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft Tissue Sarcomas: Preoperative Predictive Histopathological Grading Based on Radiomics of MRI.
    Zhang Y; Zhu Y; Shi X; Tao J; Cui J; Dai Y; Zheng M; Wang S
    Acad Radiol; 2019 Sep; 26(9):1262-1268. PubMed ID: 30377057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
    Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
    Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
    Wang H; Xu X; Zhang X; Liu Y; Ouyang L; Du P; Li S; Tian Q; Ling J; Guo Y; Lu H
    Eur Radiol; 2020 Sep; 30(9):4816-4827. PubMed ID: 32318846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generative adversarial network-based super-resolution of diffusion-weighted imaging: Application to tumour radiomics in breast cancer.
    Fan M; Liu Z; Xu M; Wang S; Zeng T; Gao X; Li L
    NMR Biomed; 2020 Aug; 33(8):e4345. PubMed ID: 32521567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.